Genome Biology (May 2020)

A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk

  • Andrew J. Gentles,
  • Angela Bik-Yu Hui,
  • Weiguo Feng,
  • Armon Azizi,
  • Ramesh V. Nair,
  • Gina Bouchard,
  • David A. Knowles,
  • Alice Yu,
  • Youngtae Jeong,
  • Alborz Bejnood,
  • Erna Forgó,
  • Sushama Varma,
  • Yue Xu,
  • Amanda Kuong,
  • Viswam S. Nair,
  • Rob West,
  • Matt van de Rijn,
  • Chuong D. Hoang,
  • Maximilian Diehn,
  • Sylvia K. Plevritis

DOI
https://doi.org/10.1186/s13059-020-02019-x
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 22

Abstract

Read online

Abstract Background Tumors comprise a complex microenvironment of interacting malignant and stromal cell types. Much of our understanding of the tumor microenvironment comes from in vitro studies isolating the interactions between malignant cells and a single stromal cell type, often along a single pathway. Result To develop a deeper understanding of the interactions between cells within human lung tumors, we perform RNA-seq profiling of flow-sorted malignant cells, endothelial cells, immune cells, fibroblasts, and bulk cells from freshly resected human primary non-small-cell lung tumors. We map the cell-specific differential expression of prognostically associated secreted factors and cell surface genes, and computationally reconstruct cross-talk between these cell types to generate a novel resource called the Lung Tumor Microenvironment Interactome (LTMI). Using this resource, we identify and validate a prognostically unfavorable influence of Gremlin-1 production by fibroblasts on proliferation of malignant lung adenocarcinoma cells. We also find a prognostically favorable association between infiltration of mast cells and less aggressive tumor cell behavior. Conclusion These results illustrate the utility of the LTMI as a resource for generating hypotheses concerning tumor-microenvironment interactions that may have prognostic and therapeutic relevance.